| Volume 4, 2000 Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Chronic Neuropathic Pain: Pharmacological Interventions in New Millennium
Jones Marty
|
Jan/Feb 2000
Pg. 6-15
|
The Psychology of Pain
Jones Marty
|
Jan/Feb 2000
Pg. 12-13
|
Opioids: A Review of the Pharmacology
Ford Peter R
|
Jan/Feb 2000
Pg. 17-20
|
Fibromyalgia
Oberlander Kevin
|
Jan/Feb 2000
Pg. 21-23
|
Compounding Intrathecal Medications
Vidrine Eric
|
Jan/Feb 2000
Pg. 24-25
|
Book Review: The NMDA Receptor
Jones Marty
|
Jan/Feb 2000
Pg. 26-27
|
Postherpetic Neuralgia
Angelle Patsy
|
Jan/Feb 2000
Pg. 27-29
|
Compounding Software: An Evaluation
Allen Loyd V Jr
|
Jan/Feb 2000
Pg. 32-35
|
Marketing Your Prescription Compounding Practice: Part One
Letendre William R, Jackson Richard A
|
Jan/Feb 2000
Pg. 36-38
|
Marketing Tip: Marketing Reps Can Help
Capps Shelly
|
Jan/Feb 2000
Pg. 39
|
Profile of a Practice
Davis Jeanie Lerche
|
Jan/Feb 2000
Pg. 40-41
|
Particulates in Parenterals
Allen Loyd V Jr
|
Jan/Feb 2000
Pg. 43
|
The Basics of Compounding: Compounding Medication Sticks
Allen Loyd V Jr
|
Jan/Feb 2000
Pg. 44-47
|
Clear-Stick Base
Allen Loyd V Jr
|
Jan/Feb 2000
Pg. 45
|
Styptic Pencil
Allen Loyd V Jr
|
Jan/Feb 2000
Pg. 45
|
Styptic Pencil (Crayon Type)
Allen Loyd V Jr
|
Jan/Feb 2000
Pg. 45
|
Analgesic Medication Stick
Allen Loyd V Jr
|
Jan/Feb 2000
Pg. 45
|
Amitriptyline HCl 2% and Baclofen 2% in PLO
Allen Loyd V Jr
|
Jan/Feb 2000
Pg. 50
|
Capsaicin 0.075%, Ketamine HCl 2% and Ketoprofen 10% in PLO
Allen Loyd V Jr
|
Jan/Feb 2000
Pg. 51
|
Capsicum 0.32%, Methyl Salicylate 25% and Menthol 10% Analgesic Cream
Allen Loyd V Jr
|
Jan/Feb 2000
Pg. 52
|
Clonidine HCl 1-mg/g in VanPen Cream
Allen Loyd V Jr
|
Jan/Feb 2000
Pg. 53
|
Cyclobenzaprine 1% and Guaifenesin 10% in Speed Gel
Allen Loyd V Jr
|
Jan/Feb 2000
Pg. 54
|
Dyclonine HCl 1-mg and Diphenhydramine HCl 10-mg Anesthetic Troches
Allen Loyd V Jr
|
Jan/Feb 2000
Pg. 55
|
Fentanyl 50-mcg Chewable Gummy Gels
Allen Loyd V Jr
|
Jan/Feb 2000
Pg. 56
|
Fentanyl 25-mcg/0.1-mL Nasal Spray
Allen Loyd V Jr
|
Jan/Feb 2000
Pg. 57
|
Morphine Sulfate 2.5-mg/mL Inhalation Solution
Allen Loyd V Jr
|
Jan/Feb 2000
Pg. 58
|
Shingles Ointment/Cream
Allen Loyd V Jr
|
Jan/Feb 2000
Pg. 59
|
Stiffening Agents, Featured Excipient:
Allen Loyd V Jr
|
Jan/Feb 2000
Pg. 60-62
|
Calculations
Prince Shelly J
|
Jan/Feb 2000
Pg. 63
|
Calibration of Hot Plates
Allen Loyd V Jr
|
Jan/Feb 2000
Pg. 64-65
|
Stability of Alatrofloxacin Mesylate in 5% Dextrose Injection and 0.45% Sodium-Chloride Injection
Gupta Vishnu D, Bailey RE
|
Jan/Feb 2000
Pg. 66-68
|
Naratriptan HCl in Extemporaneously Compounded Oral Suspensions
Zhang Yanping, Trissel Lawrence A, Fox Janet L
|
Jan/Feb 2000
Pg. 69-71
|
Physicochemical Stability of Compounded Creams Containing alpha-Hydroxy Acids
de Villiers Melgardt M, Narsai Kirti, van der Watt Jakkie G
|
Jan/Feb 2000
Pg. 72-75
|
The Clinical Pharmacist's Role in Compounding for the Diabetic Patient
Harshbarger Robert, Harshbarger Diana
|
Mar/Apr 2000
Pg. 84-87
|
Sugar Substitutes
Kloesel Lawson
|
Mar/Apr 2000
Pg. 86-87
|
Complications of Diabetes
Key David M
|
Mar/Apr 2000
Pg. 88-90
|
Transdermal Gels in the Treatment of Diabetic Neuropathy
Hodges Caroline J, Jones Thomas H, Willoughby David L
|
Mar/Apr 2000
Pg. 91-93
|
L-Arginine and Ascorbic Acid for Diabetic Foot Ulcers
Gorman Shellie
|
Mar/Apr 2000
Pg. 94-96
|
Natural-Product Therapies for Treating Diabetic Neuropathy
Anderson Constance
|
Mar/Apr 2000
Pg. 98-100
|
Patient Handout: Diabetes Management Guidelines
Anderson Constance
|
Mar/Apr 2000
Pg. 100
|
Complementary Medicine - A Wellness Plan for People with Diabetes
Singer Debra
|
Mar/Apr 2000
Pg. 101-102
|
Diabetes Book Reviews
Reed-Kane Dana
|
Mar/Apr 2000
Pg. 103-104
|
Analytical Testing of Extemporaneously Compounded Preparations
Kupiec Thomas C
|
Mar/Apr 2000
Pg. 105-107
|
Natural Estrogens: A Review of the Primary Literature
Glasnapp Andrew
|
Mar/Apr 2000
Pg. 110-114
|
Marketing Your Prescription Compounding Practice: Part Two
Letendre William R, Jackson Richard A
|
Mar/Apr 2000
Pg. 115-117
|
Profile of a Practice
Davis Jeanie Lerche
|
Mar/Apr 2000
Pg. 120-121
|
Basics of Compounding: Compounding Solutions
Allen Loyd V Jr
|
Mar/Apr 2000
Pg. 122-125
|
Chlorhexidine 0.2% Oral Rinse
Allen Loyd V Jr
|
Mar/Apr 2000
Pg. 128
|
Coenzyme Q10 200-mg Chewable Troches
Allen Loyd V Jr
|
Mar/Apr 2000
Pg. 129
|
Diabetic Foot-Care Ointments
Allen Loyd V Jr
|
Mar/Apr 2000
Pg. 130
|
Diabetic Skin-Ulcer Cream
Allen Loyd V Jr
|
Mar/Apr 2000
Pg. 131
|
Ketamine HCl 5% and Amitriptyline HCl 2% in PLO
Allen Loyd V Jr
|
Mar/Apr 2000
Pg. 132
|
Ketamine HCl 10%, Gabapentin 6%, Baclofen 2%, Amitriptyline HCl 2% and Clonidine HCl 0.1% in PLO
Allen Loyd V Jr
|
Mar/Apr 2000
Pg. 133
|
Lipoic Acid 200-mg Chewable Troches
Allen Loyd V Jr
|
Mar/Apr 2000
Pg. 134
|
Nifedipine 160-mg/mL in PLO
Allen Loyd V Jr
|
Mar/Apr 2000
Pg. 135
|
Sugar-Free Suspension Structured Vehicle, USP
Allen Loyd V Jr
|
Mar/Apr 2000
Pg. 136
|
Vanadyl Sulfate 10-mg Capsules
Allen Loyd V Jr
|
Mar/Apr 2000
Pg. 137
|
Official Solvents, Featured Excipient:
Allen Loyd V Jr
|
Mar/Apr 2000
Pg. 139-142
|
Standard Operating Procedure for Cleaning Glassware
Allen Loyd V Jr
|
Mar/Apr 2000
Pg. 144
|
Calculations
Prince Shelly J
|
Mar/Apr 2000
Pg. 145
|
Some Studies of the Stability of Compounded Cefazolin Ophthalmic Solution
Kommanaboyina Brahmaiah, Lindauer Richard F, Rhodes Christopher T, Grady Lee T
|
Mar/Apr 2000
Pg. 146-149
|
Effect of Some Antioxidants on the Color Change of White Lotion
Boonme Prapaporn
|
Mar/Apr 2000
Pg. 154-155
|
Stability of Ranitidine Hydrochloride with Cefazolin Sodium, Cefbuperazone Sodium, Cefoxitin Sodium and Cephalothin Sodium during Simulated Y-Site Administration
Inagaki Kazuhiro, Miyamoto Yuriko, Kurata Niroko, Nakane Shigeki, Gill Mark A, Nishida Mikio
|
Mar/Apr 2000
Pg. 150-153
|
Compounding Ear, Nose and Throat Preparations
Allen Loyd V Jr
|
May/Jun 2000
Pg. 164-169
|
Benzocaine Otic Solution
Allen Loyd V Jr
|
May/Jun 2000
Pg. 165
|
General Nasal Solution Vehicle
Allen Loyd V Jr
|
May/Jun 2000
Pg. 166
|
Desmopressin Acetate Nasal Solution 0.033 mg/mL
Allen Loyd V Jr
|
May/Jun 2000
Pg. 167
|
Saline Nasal Mist
Allen Loyd V Jr
|
May/Jun 2000
Pg. 167
|
Atropine Sulfate 0.5% Nasal Solution
Allen Loyd V Jr
|
May/Jun 2000
Pg. 167
|
Xylometazoline 1-mg/mL HCl Nasal Drops
Allen Loyd V Jr
|
May/Jun 2000
Pg. 169
|
Progesterone 20-mg/mL Nasal Solution
Allen Loyd V Jr
|
May/Jun 2000
Pg. 169
|
Scopolamine Hydrobromide 0.4-mg per 0.1-mL Nasal Solution
Allen Loyd V Jr
|
May/Jun 2000
Pg. 169
|
Xylitol in the Prevention of Otitis Media
Glasnapp Andrew
|
May/Jun 2000
Pg. 171-174
|
Xylitol 40% Syrup
Allen Loyd V Jr
|
May/Jun 2000
Pg. 174
|
Xylitol Troches
Allen Loyd V Jr
|
May/Jun 2000
Pg. 174
|
Pilocarpine Oral Solution
Allen Loyd V Jr
|
May/Jun 2000
Pg. 177
|
Sildenafil 0.2% Otic Drops
Holland Robert T, Quisling Richard
|
May/Jun 2000
Pg. 175
|
Xerostomia
Kuntz Rachael, Allen Michelle, Osburn Jennifer
|
May/Jun 2000
Pg. 176-177
|
Pharmacological Treatment Options for Snoring
Osburn Jennifer, Allen Michelle, Kuntz Rachael
|
May/Jun 2000
Pg. 179
|
Compounding OTC Drugs: A Legal Perspective
Gibbs Jeffrey N, Mazan Kate Duffy
|
May/Jun 2000
Pg. 180-181
|
Needleless Infusion Systems
Allen Loyd V Jr, Mathews Elizabeth
|
May/Jun 2000
Pg. 183
|
Pharmacy Licensure Requirements
Allen Loyd V Jr
|
May/Jun 2000
Pg. 186
|
Wish You Were Here: Oklahoma Frontier Drug Store Museum
Worthen Dennis B
|
May/Jun 2000
Pg. 188-189
|
Three Drug Stability Lives
Newton David W
|
May/Jun 2000
Pg. 190-193
|
Cellulose Applications for the Pharmaceutical Industry
Nicoll Harold
|
May/Jun 2000
Pg. 196-197
|
Marketing Your Prescription Compounding Practice: Part Three
Letendre William R, Jackson Richard A
|
May/Jun 2000
Pg. 199-202
|
Profile of a Practice: Surviving the Competition
Davis Jeanie Lerche
|
May/Jun 2000
Pg. 203
|
The Future of Compounding: An Industry Perspective
Capps Shelly, Winckler Susan C, Anthony Calvin J, Halperin Jerome A
|
May/Jun 2000
Pg. 204-205
|
Amphotericin B 100-mg Troches
Allen Loyd V Jr
|
May/Jun 2000
Pg. 208
|
Dimethyl Sulfone 16% Nasal Solution
Allen Loyd V Jr
|
May/Jun 2000
Pg. 209
|
Miconazole 2% Otic Powder
Allen Loyd V Jr
|
May/Jun 2000
Pg. 210
|
Misoprostol 0.001% and Lidocaine 0.5% Oral Rinse
Allen Loyd V Jr
|
May/Jun 2000
Pg. 211
|
Misoprostol 0.0027% Mucoadhesive Powder
Allen Loyd V Jr
|
May/Jun 2000
Pg. 212
|
Mupirocin 1% Nasal Drops
Allen Loyd V Jr
|
May/Jun 2000
Pg. 213
|
Nystatin 250,000-Unit and/or Tetracaine HCl 0.025% Popsicles
Allen Loyd V Jr
|
May/Jun 2000
Pg. 214
|
Saliva Substitute for Dry Mouth/Throat
Allen Loyd V Jr
|
May/Jun 2000
Pg. 215
|
Stomatitis Preparations
Allen Loyd V Jr
|
May/Jun 2000
Pg. 216-217
|
Tonicity-Adjusting Agents, Featured Excipient:
Allen Loyd V Jr
|
May/Jun 2000
Pg. 218-220
|
Calculations
Prince Shelly J
|
May/Jun 2000
Pg. 221
|
Assignment of Beyond-Use Dates
Allen Loyd V Jr
|
May/Jun 2000
Pg. 222
|
Dry Heat Sterilization of Parenteral Oil Vehicles
Kupiec Thomas C, Matthews Parrish, Ahmad Riaz
|
May/Jun 2000
Pg. 223-224
|
Stability of Morphine-Ketamine Mixtures in 0.9% Sodium Chloride Injection Packaged in Syringes, Plastic Bags and MEDICATION CASSETTEª Reservoirs
Roy Julie J, Hildgen Patrice
|
May/Jun 2000
Pg. 225-228
|
Simple High-Performance Liquid Chromatographic Method for Simultaneous Determination of Fusidic Acid and Betamethasone Dipropionate in a Cream Formulation
Peh Kok-Khiang, Tan Yvonne Tze-Fung
|
May/Jun 2000
Pg. 229-231
|
Stability of an Oral Liquid Dosage Form of Trovafloxacin Mesylate and Its Quantitation in Tablets Using High-Performance Liquid Chromatography
Gupta Vishnu D
|
May/Jun 2000
Pg. 233-235
|
Hospice and the Role of the Compounding Pharmacist
Carling Maureen A
|
Jul/Aug 2000
Pg. 246-249
|
Nausea and Vomiting in Hospice Patients
Boomsma Diane
|
Jul/Aug 2000
Pg. 250-251
|
Ketamine for Pain in Hospice Patients
Wood Robert M
|
Jul/Aug 2000
Pg. 253-254
|
Custom-Making Medications for the Hospice Patient
Horwitz Robert
|
Jul/Aug 2000
Pg. 255-256
|
Body-Wash Formula
Horwitz Robert
|
Jul/Aug 2000
Pg. 255
|
Rinseless Shampoo
Horwitz Robert
|
Jul/Aug 2000
Pg. 255
|
Dry Mouth Spray
Horwitz Robert
|
Jul/Aug 2000
Pg. 255
|
Surviving Cancer - How the Compounding Pharmacist Can Help
Maddox Suzan
|
Jul/Aug 2000
Pg. 257-260
|
Compounding Using Hazardous Drugs
Lau Kellie
|
Jul/Aug 2000
Pg. 261-263
|
Providing Positive Outcomes through Compounding for Animal Cancer Patients
Davidson Gigi S
|
Jul/Aug 2000
Pg. 264-272
|
Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease
Glasnapp Andrew, Schaefer Erin
|
Jul/Aug 2000
Pg. 276-279
|
NADH Capsules
Glasnapp Andrew, Schaefer Erin
|
Jul/Aug 2000
Pg. 278
|
Short Communication: Compounding for Implantable Pumps
Molitor Richard
|
Jul/Aug 2000
Pg. 280
|
Ambulatory Pumps: Part I of a Three-Part Series - Peristaltic Infusion Devices Review
Ashworth Lisa D
|
Jul/Aug 2000
Pg. 281-285
|
Profile of a Practice
Hudson Sonora
|
Jul/Aug 2000
Pg. 287
|
Book Reviews
Reed-Kane Dana
|
Jul/Aug 2000
Pg. 288
|
Basics of Compounding: Compounding Suppositories: Part I - Theoretical Considerations
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 289-293
|
Dacarbazine 8-mg/mL, Doxorubicin HCl 0.8-mg/mL and Ondansetron 0.64-mg/mL injection
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 296
|
Dexamethasone 1.2%, Lorazepam 0.1%, Haloperidol 0.1%, Diphenhydramine HCl 2.4% and Metoclopramide HCl 2.4% in PLO
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 297
|
Doxorubicin HCl 0.4-mg/mL, Ondansetron HCl 0.48-mg/mL and Vincristine Sulfate 14-mcg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 298
|
Fentanyl 100-mcg/0.1-mL and Promethazine HCl 12.5-mg/0.1-mL in PLO
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 299
|
Fentanyl 35-mcg/mL, Bupivacaine HCl 1-mg/mL and Clonidine HCl 9-mcg/mL Intrathecal Solution
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 300
|
Lidocaine HCl 2%, Misoprostol 0.003% and Phenytoin 2.5% Topical Gel for Decubitus Ulcers
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 301
|
Misoprostol 0.0024% Mouth Rinse for Oral Ulcerations
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 302
|
Morphine Sulfate 20-mg/mL and Clonidine HCl 10-mcg/mL Epidural Injection
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 303
|
Nasogastric Tube/Percutaneous Endoscopic Gastrostomy Tube Suspension Formula
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 304
|
Ondansetron HCl 8-mg/mL in PLO
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 305
|
Capsule and Tablet Diluents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 306-310
|
Basic Compounding Documentation: The Master Formula Form
Tenreiro Kim
|
Jul/Aug 2000
Pg. 313-312
|
Calculations
Prince Shelly J
|
Jul/Aug 2000
Pg. 314
|
Experimenting with a New Emulsifying Agent (Tahini) in Mineral Oil Emulsion
Al-Achi Antoine, Greenwood Robert, Akin-Isijola Austin
|
Jul/Aug 2000
Pg. 315-317
|
Microbiological Stability of a Fentanyl, Bupivacaine and Clonidine Mixture in a 0.9% Sodium Chloride Infusion Stored in Syringes and Reservoirs
Jappinen Annaliisa L, Naaranlahti Toivo J, Kokki Hannu, Ojanen Tarja, Rasi Anu
|
Jul/Aug 2000
Pg. 318-319
|
Stability of 5-Fluorouracil in an Extemporaneously Compounded Ophthalmic Solution
Fuhrman L Clifton, Godwin Donald A, Davis R Alan
|
Jul/Aug 2000
Pg. 320-323
|
Human Immunodeficiency Virus and the Acquired Immune Deficiency Syndrome
Mathews Elizabeth
|
Sep/Oct 2000
Pg. 334
|
Clinical Management and Review of Sjogren's Syndrome
Dyke Shannon
|
Sep/Oct 2000
Pg. 338
|
Sodium Fluoride Gel (0.5% Fluoride)
Dyke Shannon
|
Sep/Oct 2000
Pg. 339
|
Clotrimazole 10 mg Base A Troche
Dyke Shannon
|
Sep/Oct 2000
Pg. 339
|
Saliva Substitute
Dyke Shannon
|
Sep/Oct 2000
Pg. 340
|
Compounding with Beta-1, 3-D-Glucan
Keller Ted
|
Sep/Oct 2000
Pg. 342
|
Psoriasis
Fenrich Jon, Vidaurri Vincent
|
Sep/Oct 2000
Pg. 346
|
Probiotics and Their Effect on Leaky Gut Syndrome and Associated Diseases
Hinze John, Mahan Tracy
|
Sep/Oct 2000
Pg. 349
|
Immune System Disorders: What's new and Interesting in Print and On-Line
Foy Elizabeth, MacCara Mary E
|
Sep/Oct 2000
Pg. 351-353
|
Transdermal Nifedipine for Wound Healing: Case Reports
Torsiello Michael J, Kopacki Matthew H
|
Sep/Oct 2000
Pg. 356
View Sample |
Wish You Were Here: Marvin Samson Center for the History of Pharmacy, University of the Sciences in Philadelphia
Worthen Dennis B
|
Sep/Oct 2000
Pg. 359
|
Profile of A Practice: Hormone Replacement Therapy in the Heartland
Hudson Sonora
|
Sep/Oct 2000
Pg. 362
|
Ambulatory Syringe Infusion Devices: A Review - Part 2
Ashworth Lisa D
|
Sep/Oct 2000
Pg. 364
|
Basics of Compounding: Compounding Suppositories Part 2
Allen Loyd V Jr
|
Sep/Oct 2000
Pg. 371
|
Artificial Tears for Dry Eyes
Allen Loyd V Jr
|
Sep/Oct 2000
Pg. 376
|
Capsicum Oleoresin 0.3% and Ketoprofen 10% in PLO Gel
Allen Loyd V Jr
|
Sep/Oct 2000
Pg. 377
|
Coal Tar Medication Stick
Allen Loyd V Jr
|
Sep/Oct 2000
Pg. 378
|
Interferon with 0.1% Nonoxynol-9 Gel
Allen Loyd V Jr
|
Sep/Oct 2000
Pg. 379
|
Interferon Ophthalmic Solution
Allen Loyd V Jr
|
Sep/Oct 2000
Pg. 380
|
Pilocarpine HCl 2-mg Troches
Allen Loyd V Jr
|
Sep/Oct 2000
Pg. 381
|
Psoriasis Nail Treatment
Allen Loyd V Jr
|
Sep/Oct 2000
Pg. 382
|
Psoriasis Ointment, Heavy Moisturizing
Allen Loyd V Jr
|
Sep/Oct 2000
Pg. 383
|
Sunscreen Gel-Alcoholic, SPF-15
Allen Loyd V Jr
|
Sep/Oct 2000
Pg. 384
|
Sunscreen Lotion, SPF-40
Allen Loyd V Jr
|
Sep/Oct 2000
Pg. 385
|
Providing Care for Diabetic Veterinary Patients
Davidson Gigi S
|
Sep/Oct 2000
Pg. 386
|
Capsule and Tablet Lubricants, Featured Excipient:
Allen Loyd V Jr
|
Sep/Oct 2000
Pg. 390
|
Calculations
Prince Shelly J
|
Sep/Oct 2000
Pg. 393
|
Basic Compounding Documentation: The Batch Control Sheet
Tenreiro Kim
|
Sep/Oct 2000
Pg. 395
|
Stability of Hydrocortisone Sodium Succinate After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Gupta Vishnu D, Ling Jie
|
Sep/Oct 2000
Pg. 396-397
|
Stability of Lisinopril Syrup (2 mg/mL) Extemporaneously Compounded from Tablets
Rose Deidra J, Webster Andrew A, English Brett A, McGuire J Michael
|
Sep/Oct 2000
Pg. 398-399
|
Pharmaceutical Profile of Vitamin C Tablets and Capsules
Al-Achi Antoine, Greenwood Robert, Nzazi Guy
|
Sep/Oct 2000
Pg. 400-403
|
Correction
|
Sep/Oct 2000
Pg. 330
|
"Natural" Isomolecular Hormone Replacement: An Evidence-Based Medicine Approach
Drisko Jeanne A
|
Nov/Dec 2000
Pg. 414-420
|
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens-Part 1
Ford Gina, Garcia Lea
|
Nov/Dec 2000
Pg. 421-422
|
Book Reviews: Women's Health
Reed-Kane Dana
|
Nov/Dec 2000
Pg. 424-425
|
Hormone Replacement Therapy: Selected Recent References
Foy Elizabeth, MacCara Mary E
|
Nov/Dec 2000
Pg. 426-427
|
Testosterone Deficiency in Men: New Treatments for Andropause
Biundo Bruce, Shippen Eugene
|
Nov/Dec 2000
Pg. 429-431
|
Compounded Testosterone Gels: A Guide for Clinicians and Pharmacists
Cutter Christopher B
|
Nov/Dec 2000
Pg. 432-437
View Sample |
Zinc Sulfate Heptahydrate 0.1% Solution
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 440
|
Managing Zinc Deficiency in an Office Setting
Norwood Charles, Chaney Bill, Moore Robert W
|
Nov/Dec 2000
Pg. 440-441
|
Disposable Ambulatory Infusion Devices: A Review - Part 3
Ashworth Lisa D
|
Nov/Dec 2000
Pg. 442-443
|
On-Line Billing for Custom Compounds: The Third-Party Payor
Heckman H Edward
|
Nov/Dec 2000
Pg. 445-446
|
Fentanyl Troche Protocol
Roberts Bruce T
|
Nov/Dec 2000
Pg. 447
|
Profile of a Practice: Med Specialties Pharmacy
Mathew Brina
|
Nov/Dec 2000
Pg. 448-449
|
Wish You Were Here: Donald F. Salvatori California Pharmacy Museum
Worthen Dennis B
|
Nov/Dec 2000
Pg. 450-451
|
Basics of Compounding - Inhalation Preparations
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 452-455
|
Albuterol Sulfate 0.5% Inhalant Solution (Preservative Free)
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 455
|
Flunisolide 0.025% Inhalation Solution (Preservative Free)
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 455
|
Ipratropium Bromide 0.02% Solution (Preservative Free)
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 455
|
Terbutaline 0.1% Inhalant Solution (Preservative Free)
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 455
|
Albuterol-Cromolyn-Betamethasone for Inhalation (Preservative Free)
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 455
|
Albuterol-Ipratropium for Inhalation (Preservative Free)
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 455
|
Beclomethasone Dipropionate 0.042% Nasal Solution (Preservative Free)
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 455
|
Estriol and Estradiol 2.5-mg, Progesterone 50-mg, and Testosterone 1-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 458
|
Estriol and Estradiol 1.25, 2.5, and 5-mg (BiEst) Capsules
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 459
|
Estrogen 0.625-mg/5-g Vaginal Gel
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 460
|
Progesterone Cycle Pack 35/50/75/100-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 461
|
Testosterone 1-mg/0.1-mL Nasal Spray
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 462
|
Testosterone 1-mg/0.1-mL in a PLO Gel
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 463
|
Testosterone 1-mg/0.1-mL Topical Vaginal/Scrotal Spray
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 464
|
Triple Estrogen 2.5-mg/0.1-mL PLO
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 465
|
Triple Estrogen 2.5-mg/0.1-mL Sublingual Drops
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 466
|
Triple Estrogen 2.5-mg Tablet Triturates
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 467
|
Estrogen Use in Dogs: Indications and Complications
Davidson Gigi S
|
Nov/Dec 2000
Pg. 468-470
|
Oleaginous Vehicles, Featured Excipient:
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 470-472
|
Calculations
Prince Shelly J
|
Nov/Dec 2000
Pg. 473
|
Assignment of a Beyond-Use Date for Compounded Preparations
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 474-475
|
Compatibility and Stability of Linezolid Injection Admixed with Gentamicin Sulfate and Tobramycin Sulfate
Xu Quanyun A, Trissel Lawrence A, Zhang Yanping, Williams Kimberly Y
|
Nov/Dec 2000
Pg. 476-479
|
Stability of Nafcillin Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Gupta Vishnu D, Ling Jie
|
Nov/Dec 2000
Pg. 480-481
|
Stability of Levothyroxine Sodium Injection in Polypropylene Syringes
Gupta Vishnu D
|
Nov/Dec 2000
Pg. 482-483
|
